109 related articles for article (PubMed ID: 8531419)
1. CCKB-receptor activation augments the long-term potentiation in guinea pig hippocampal slices.
Yasui M; Kawasaki K
Jpn J Pharmacol; 1995 Aug; 68(4):441-7. PubMed ID: 8531419
[TBL] [Abstract][Full Text] [Related]
2. Cholecystokinin (CCK-8S) prolongs 'unsaturated' theta-pulse induced long-term potentiation in rat hippocampal CA1 in vitro.
Balschun D; Reymann KG
Neuropeptides; 1994 Jun; 26(6):421-7. PubMed ID: 7936127
[TBL] [Abstract][Full Text] [Related]
3. CCKA and CCKB receptor subtypes both mediate the effects of CCK-8 on myenteric neurons in the guinea-pig ileum.
Schutte IW; Akkermans LM; Kroese AB
J Auton Nerv Syst; 1997 Dec; 67(1-2):51-9. PubMed ID: 9470144
[TBL] [Abstract][Full Text] [Related]
4. CCKB receptors mediate CCK-8S-induced activation of dorsal hippocampus CA3 pyramidal neurons: an in vivo electrophysiological study in the rat.
Gronier B; Debonnel G
Synapse; 1995 Oct; 21(2):158-68. PubMed ID: 8584977
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective effect of cholecystokininB receptor antagonist on ischemia-induced decrease in CA1 presynaptic fiber spikes in rat hippocampal slices.
Minamoto Y; Tanaka T; Shibata S; Watanabe S
Neurosci Lett; 1994 Feb; 167(1-2):81-4. PubMed ID: 8177534
[TBL] [Abstract][Full Text] [Related]
6. Cholecystokinin depolarizes rat thalamic reticular neurons by suppressing a K+ conductance.
Cox CL; Huguenard JR; Prince DA
J Neurophysiol; 1995 Sep; 74(3):990-1000. PubMed ID: 7500167
[TBL] [Abstract][Full Text] [Related]
7. Direct contractile effect of cholecystokinin octapeptide on caecal circular smooth muscle cells of guinea pig via both CCK-A and CCK-B/gastrin receptors.
Motomura Y; Chijiiwa Y; Iwakiri Y; Nawata H
Life Sci; 1997; 60(7):499-504. PubMed ID: 9042379
[TBL] [Abstract][Full Text] [Related]
8. The excitatory effect of cholecystokinin on rat neostriatal neurons: ionic and molecular mechanisms.
Wu T; Wang HL
Eur J Pharmacol; 1996 Jun; 307(2):125-32. PubMed ID: 8832213
[TBL] [Abstract][Full Text] [Related]
9. Expression of two different cholecystokinin receptors in Xenopus oocytes injected with mRNA from rabbit pancreas and rat hippocampus.
Shigeri Y; Shinohara S; Murata S; Fujimoto M; Kawasaki K
Jpn J Pharmacol; 1996 Sep; 72(1):9-15. PubMed ID: 8902594
[TBL] [Abstract][Full Text] [Related]
10. The use of receptor desensitization to analyse CCKA and CCKB/gastrin receptors coupled to contraction in guinea-pig stomach muscle.
Bishop LA; Gerskowitch VP; Hull RA; Shankley NP; Black JW
Br J Pharmacol; 1995 Jan; 114(2):339-48. PubMed ID: 7881733
[TBL] [Abstract][Full Text] [Related]
11. Electrophysiological changes in rat hippocampal pyramidal neurons produced by cholecystokinin octapeptide.
Shinohara S; Kawasaki K
Neuroscience; 1997 Jun; 78(4):1005-16. PubMed ID: 9174069
[TBL] [Abstract][Full Text] [Related]
12. Are C-terminal octapeptide of cholecystokinin and [Leu11]gastrin-(5-17) different in stimulating acid secretion in isolated rabbit gastric glands?
Oiry C; Galleyrand JC; Lima-Leite AC; Fulcrand P; Martinez J
Eur J Pharmacol; 1995 Dec; 294(2-3):511-9. PubMed ID: 8750713
[TBL] [Abstract][Full Text] [Related]
13. Short-term facilitation evoked during brief afferent tetani is not altered by long-term potentiation in the guinea-pig hippocampal CA1 region.
Pananceau M; Chen H; Gustafsson B
J Physiol; 1998 Apr; 508 ( Pt 2)(Pt 2):503-14. PubMed ID: 9508813
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological properties of ureido-acetamides, new potent and selective non-peptide CCKB/gastrin receptor antagonists.
Bertrand P; Böhme GA; Durieux C; Guyon C; Capet M; Jeantaud B; Boudeau P; Ducos B; Pendley CE; Martin GE
Eur J Pharmacol; 1994 Sep; 262(3):233-45. PubMed ID: 7813588
[TBL] [Abstract][Full Text] [Related]
15. Cholecystokinin-octapeptide restored morphine-induced hippocampal long-term potentiation impairment in rats.
Wen D; Zang G; Sun D; Yu F; Mei D; Ma C; Cong B
Neurosci Lett; 2014 Jan; 559():76-81. PubMed ID: 24309294
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the anoxia-induced long-term synaptic potentiation in area CA1 of the rat hippocampus.
Hsu KS; Huang CC
Br J Pharmacol; 1997 Oct; 122(4):671-81. PubMed ID: 9375963
[TBL] [Abstract][Full Text] [Related]
17. The effect of a new water-soluble sedative-hypnotic drug, JM-1232(-), on long-term potentiation in the CA1 region of the mouse hippocampus.
Takamatsu I; Sekiguchi M; Yonamine R; Wada K; Kazama T
Anesth Analg; 2011 Nov; 113(5):1043-9. PubMed ID: 21788318
[TBL] [Abstract][Full Text] [Related]
18. CCKB receptor activation protects CA1 neurons from ischemia-induced dysfunction in stroke-prone spontaneously hypertensive rats hippocampal slices.
Yasui M; Kawasaki K
Neurosci Lett; 1995 May; 191(1-2):99-102. PubMed ID: 7659302
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological profile of T-0632, a novel potent and selective CCKA receptor antagonist, in vitro.
Taniguchi H; Yazaki N; Endo T; Nagasaki M
Eur J Pharmacol; 1996 May; 304(1-3):147-54. PubMed ID: 8813597
[TBL] [Abstract][Full Text] [Related]
20. Peptoid CCK receptor antagonists: pharmacological evaluation of CCKA, CCKB and mixed CCKA/B receptor antagonists.
Singh L; Field MJ; Hill DR; Horwell DC; McKnight AT; Roberts E; Tang KW; Woodruff GN
Eur J Pharmacol; 1995 Nov; 286(2):185-91. PubMed ID: 8605955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
